Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study.

Stefan Hohaus, Angelo M. Carella, Carmino A. De Souza, Stefano Luminari, Luigi Marcheselli, Annalisa Chiappella, Alice Di Rocco, Marina Cesaretti, Andrea Rossi, Luigi Rigacci, Gianluca Gaidano, Francesco Merli, Michele Spina, Caterina Stelitano, Anna Barbui, Benedetta Puccini, Eliana C. Miranda, Annalisa Guida, Massimo Federico

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

35 Citazioni (Scopus)

Abstract

Male gender was recently reported as an adverse prognostic factor in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone). We conducted a retrospective study of adult patients with DLBCL initially treated with rituximab containing regimens between 2001 and 2007. Patients were identified from the clinical archives of 43 Italian and Brazilian institutions. The principal endpoint was overall survival (OS). One thousand seven hundred and ninety-three patients were fully eligible for the study. Thirty-eight percent, 27%, 22% and 12% of patients had an International Prognostic Index (IPI) score of 0-1, 2, 3 and 4-5, respectively; 53% were males. After a median follow-up of 36 months (1-106), the 5-year OS was 76% (95% confidence interval 74-78%). In univariate analysis, male gender was an adverse prognostic factor with a hazard ratio of 1.52. In multivariate analysis, when adjusted by IPI, again gender maintained its prognostic relevance, showing an independent additive effect. In conclusion, in patients with DLBCL treated with rituximab containing regimens, gender may increase the predictive power of the IPI. Based on these results, given possible differences in blood clearance of rituximab between males and females, the benefit of higher doses of rituximab in males should be explored.
Lingua originaleEnglish
pagine (da-a)53-57
Numero di pagine5
RivistaLEUKEMIA & LYMPHOMA
Volume2013
DOI
Stato di pubblicazionePubblicato - 2012

Keywords

  • Diffuse Large B cell lymphoma
  • Prognosis

Fingerprint Entra nei temi di ricerca di 'Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study.'. Insieme formano una fingerprint unica.

Cita questo